Transcranial direct current stimulation raises glutamate levels in humans

A new study in Biological Psychiatry is the first to measures changes in brain metabolism during tDCS. Led by senior author Shirley Fecteau of the Université Laval in Quebec, Canada, the study reports that tDCS increases levels of the neurotransmitters glutamate + glutamine-glutamate is the main activating chemical messenger in the brain-and N-acetylaspartate (NAA), an indicator of neuronal health. Both of these neurotransmitters support learning and adaptation in the brain.

"These interesting data provide chemical evidence suggesting that tDCS may activate the human cerebral cortex," said John Krystal, Editor of Biological Psychiatry. "This type of change would seem to be critical for producing behavioral and perhaps therapeutic effects."

In the study, the researchers applied a single tDCS session to 15 healthy participants for 30 minutes at a current intensity of 1 mA, considered a mild dose. They stimulated the prefrontal cortex, a brain region involved in behavior and cognition. During stimulation, the researchers acquired magnetic resonance spectroscopy scans to measure changes in neurotransmitter levels in the prefrontal cortex and in the striatum, an important region involved in many functions including reward and learning.

In participants who received tDCS, first author Antoine Hone-Blanchet measured a rapid increase in prefrontal NAA, within 15 minutes of stimulation, and in striatal glutamate + glutamine within 30 minutes. The levels returned to normal immediately at the end of the session. According to Fecteau, these results suggest that tDCS has a rapid but short-lived excitatory effect at and downstream from the stimulation site.

"These findings need to be replicated with greater sample size, but also compel for investigation on the neural effects of tDCS," said Fecteau, noting that the scientific community and general population have been increasingly using tDCS over the prefrontal cortex in recent years.

Researchers still do not know the effects of repeated or longer-lasting stimulation on neurochemical activity, which may be beneficial or detrimental, depending on the user, said Fecteau. Understanding the potential impact of the tool, positive and negative, will help harness its utility for effective and safe use in healthy and clinical populations.